EDITORIAL
Published on 06 Apr 2021
Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
doi 10.3389/fcell.2021.662761
- 1,100 views
- Frontiers in Cell and Developmental Biology
- Epigenomics and Epigenetics
- Research Topics
- Epigenetic Therapy with Histone Deacetylase Inhibitors: Implications for Cancer Treatment
Epigenetic Therapy with Histone Deacetylase Inhibitors: Implications for Cancer Treatment
35k
Total downloads
159k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 28 Jan 2021
Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus
doi 10.3389/fcell.2020.592868
- 5,804 views
- 27 citations
ORIGINAL RESEARCH
Published on 09 Oct 2020
Schedule-Dependent Synergy Between the Histone Deacetylase Inhibitor Belinostat and the Dihydrofolate Reductase Inhibitor Pralatrexate in T-and B-cell Lymphoma Cells in vitro
doi 10.3389/fcell.2020.577215
- 2,339 views
- 7 citations
MINI REVIEW
Published on 09 Oct 2020
Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
doi 10.3389/fcell.2020.582370
- 6,558 views
- 56 citations
REVIEW
Published on 29 Sep 2020
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
doi 10.3389/fcell.2020.576946
- 39,504 views
- 230 citations
REVIEW
Published on 11 Sep 2020
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
doi 10.3389/fgene.2020.578011
- 19,360 views
- 127 citations
REVIEW
Published on 03 Sep 2020
Recent Update of HDAC Inhibitors in Lymphoma
doi 10.3389/fcell.2020.576391
- 11,037 views
- 64 citations
ORIGINAL RESEARCH
Published on 17 Aug 2020
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
doi 10.3389/fcell.2020.00732
- 3,880 views
- 25 citations
ORIGINAL RESEARCH
Published on 11 Aug 2020
2-O-Methylmagnolol, a Magnolol Derivative, Suppresses Hepatocellular Carcinoma Progression via Inhibiting Class I Histone Deacetylase Expression
doi 10.3389/fonc.2020.01319
- 2,356 views
- 7 citations
BRIEF RESEARCH REPORT
Published on 05 Aug 2020
Histone Deacetylases Inhibit the Snail2-Mediated EMT During Metastasis of Hepatocellular Carcinoma Cells
doi 10.3389/fcell.2020.00752
- 3,089 views
- 20 citations
ORIGINAL RESEARCH
Published on 14 Jul 2020
Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent
doi 10.3389/fcell.2020.00454
- 2,700 views
- 13 citations
REVIEW
Published on 10 Jul 2020
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
doi 10.3389/fcell.2020.00546
- 6,211 views
- 36 citations
Published in
Frontiers in Cell and Developmental Biology
- Epigenomics and Epigenetics
Participating Journals
Frontiers in Genetics
- 2.8 impact factor
- 5.5 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 159kTopic views
- 119kArticle views
- 35kArticle downloads